Copyright
©The Author(s) 2024.
World J Gastroenterol. Sep 14, 2024; 30(34): 3894-3925
Published online Sep 14, 2024. doi: 10.3748/wjg.v30.i34.3894
Published online Sep 14, 2024. doi: 10.3748/wjg.v30.i34.3894
Figure 1 Detailed flowchart illustrates the identification and validation of the prognostic model associated with B-cell-related genes.
HCC: Hepatocellular carcinoma; TCGA: The Cancer Genome Atlas; BRGs: B-cell-related genes; TISCH2: Tumor Immune Single-Cell Hub 2; ROC: Receiver operating characteristic; KEGG: Kyoto Encyclopedia of Genes and Genomes; GO: Gene Ontology; GSEA: Gene set enrichment analysis; LASSO: Least absolute shrinkage and selection operator; ICGC: International Cancer Genome Consortium; PCA: Principal component analysis; tSNE: T-distributed stochastic neighbor embedding; GSE: Gene Expression Omnibus Series.
- Citation: Xu KQ, Gong Z, Yang JL, Xia CQ, Zhao JY, Chen X. B-cell-specific signatures reveal novel immunophenotyping and therapeutic targets for hepatocellular carcinoma. World J Gastroenterol 2024; 30(34): 3894-3925
- URL: https://www.wjgnet.com/1007-9327/full/v30/i34/3894.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i34.3894